Insider Transactions

What UROPLASTY INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Paulus Kenneth H	Director	Mar 31	Disposition to Issuer · D	−14,475	—	—	0
Wehrwein Sven	Director	Mar 31	Disposition to Issuer · D	−43,625	—	—	0
Kill Robert	President and CEO	Mar 31	Disposition to Issuer · D	−140,000	—	—	0
Kill Robert	President and CEO	Mar 31	Disposition to Issuer · D	−385,000	—	—	0
Roche Kevin H	Director	Mar 31	Disposition to Issuer · D	−57,125	—	—	0
Roche Kevin H	Director	Mar 31	Disposition to Issuer · D	−25,000	—	—	0
Reynolds Brett	Sr. Vice President and CFO	Mar 31	Disposition to Issuer · D	−138,000	—	—	0
Stauner James P	Director	Mar 31	Disposition to Issuer · D	−66,925	—	—	0
Hammers Darin	Sr VP Global Sales & Marketing	Mar 31	Disposition to Issuer · D	−131,800	—	—	0
Reynolds Brett	Senior Vice President and CFO	Jan 30	Open-market buy · P	+3,500	$1.32	+$4.62K	138,000
Reynolds Brett	Senior Vice President and CFO	Jan 30	Open-market buy · P	+300	$1.32	+$396	134,500
Reynolds Brett	Senior Vice President and CFO	Jan 30	Open-market buy · P	+1,200	$1.31	+$1.57K	134,200
Kill Robert	President and CEO	Jan 29	Open-market buy · P	+16,250	$1.28	+$20.8K	38,950
Kill Robert	President and CEO	Jan 29	Open-market buy · P	+6,150	$1.23	+$7.56K	22,700
Kill Robert	President and CEO	Jan 29	Open-market buy · P	+2,500	$1.23	+$3.07K	16,550
Kill Robert	President and CEO	Jan 29	Open-market buy · P	+100	$1.22	+$122	14,050
Roche Kevin H	Director	Jan 29	Open-market buy · P	+25,000	$1.21	+$30.3K	57,125
Roche Kevin H	Director	Jan 29	Open-market buy · P	+16,800	$1.25	+$21K	25,000
Roche Kevin H	Director	Jan 29	Open-market buy · P	+1,100	$1.24	+$1.36K	8,200
Roche Kevin H	Director	Jan 29	Open-market buy · P	+7,100	$1.23	+$8.73K	7,100

Page 1 of 14 · showing the 20 most recent Sign up free to view all 275 transactions and filter by insider →

Comments